Prediction of irinotecan toxicity in metastatic colorectal cancer patients based on machine learning models with pharmacokinetic parameters
Irinotecan (CPT-11) is a drug used against a wide variety of tumors, which can cause severe toxicity, possibly leading to the delay or suspension of the cycle, with the consequent impact on the prognosis of survival. The main goal of this work is to predict the toxicities derived from CPT-11 using a...
Main Authors: | Oyaga-Iriarte, E. (Esther), Insausti, A. (Asier), Sayar, O. (Onintza), Aldaz, A. (Azucena) |
---|---|
Format: | info:eu-repo/semantics/article |
Language: | eng |
Published: |
Elsevier BV
2021
|
Subjects: | |
Online Access: | https://hdl.handle.net/10171/61901 |
Similar Items
-
Dose-finding study and pharmacogenomic analysis of fixed-rate infusion of gemcitabine, irinotecan and bevacizumab in pretreated metastatic colorectal cancer patients
by: Abajo, A. (Ana), et al.
Published: (2014) -
Identification of predictive circulating biomarkers of bevacizumab-containing regimen efficacy in pre-treated metastatic colorectal cancer patients
by: Abajo, A. (Ana), et al.
Published: (2014) -
Mining Small Routine Clinical Data: A Population Pharmacokinetic Model and Optimal Sampling Times of Capecitabine and its Metabolites
by: Oyaga-Iriarte, E. (Esther), et al.
Published: (2021) -
Methotrexate Pharmacokinetics and Survival in Osteosarcomat
by: Aquerreta, I. (Irene), et al.
Published: (2012) -
Effectiveness of pharmacokinetic / pharmacodynamic-guided meropenem treatment in critically ill patients: A comparative cohort study
by: Aldaz, A. (Azucena), et al.
Published: (2024)